- Home
- TCRX vs KFFB Comparison
TCRX vs KFFB Comparison
Compare TCRX & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCRX | KFFB |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 45.4M |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | TCRX | KFFB |
|---|---|---|
| Price | $0.31 | $5.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 5.5K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 109.52 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $10,325,000.00 | $15,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | $36.93 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.29 | $3.01 |
| 52 Week High | $2.57 | $6.45 |
Technical Indicators
Market Signals| Indicator | TCRX | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 21.36 | 49.06 |
| Support Level | N/A | $5.42 |
| Resistance Level | $0.82 | $6.45 |
| Average True Range (ATR) | 0.05 | 0.34 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 4.94 | 21.91 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.